Wiley Blackwell

SHERPA: Unknown

People

  1. Ladanyi
    Ladanyi
  2. Hakimi
    Hakimi
  3. Solit
    Solit
  4. Berger
    Berger
  5. Russo
    Russo
  6. Coleman
    Coleman
  7. D'Angelica
    D'Angelica
  8. Jarnagin
    Jarnagin
  9. Kingham
    Kingham
  10. Motzer
    Motzer

Groups

  1. Human Oncology and Pathogenesis Program (149)
  2. GSK Faculty (133)
  3. Department of Medicine (98)
  4. Department of Pathology and Laboratory Medicine (89)
  5. Solid Tumor Oncology Division (80)
  6. Surgery (67)
  7. Survivorship Research (49)
  8. Tow Center for Developmental Oncology (TCDO) (49)
  9. Sloan Kettering Institute Postdocs (47)
  10. Genitourinary Oncology Service (43)
Search Within
  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (105)
  2. Meeting Abstract (36)
  3. Review (7)
  4. Guidelines (1)
Groups
  1. Human Oncology and Pathogenesis Program (149)
  2. GSK Faculty (133)
  3. Department of Medicine (98)
  4. Department of Pathology and Laboratory Medicine (89)
  5. Solid Tumor Oncology Division (80)
  6. Surgery (67)

More Groups

People
  1. Marc Ladanyi (31)
  2. Abraham Hakimi (25)
  3. David Solit (25)
  4. Michael Berger (22)
  5. Paul Russo (18)
  6. Jonathan Coleman (17)

More People

Years
  1. 2025 (2)
  2. 2024 (8)
  3. 2023 (9)
  4. 2022 (12)
  5. 2021 (9)
  6. 2020 (14)

More Years

Publications
  1. Cancer (40)
  2. Journal of Pathology (24)
  3. BJU International (21)
  4. Journal of Surgical Oncology (10)
  5. Histopathology (8)
  6. Hematological Oncology (6)

More Publications

Results (149)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • RAS mutations affect pattern of metastatic spread and increase propensity for brain metastasis in colorectal cancer
    Journal Article

    Yaeger, R.; Cowell, E.; Chou, J. F.; Gewirtz, A. N.; Borsu, L.; Vakiani, E.; Solit, D. B.; Rosen, N.; Capanu, M.; Ladanyi, M.; more...
    Cancer (2015)

    Fulltext@MSK | Save
  • Clinicopathologic features and outcomes of patients with lung adenocarcinomas harboring BRAF mutations in the Lung Cancer Mutation Consortium
    Journal Article

    Villaruz, L. C.; Socinski, M. A.; Abberbock, S.; Berry, L. D.; Johnson, B. E.; Kwiatkowski, D. J.; John Iafrate, A.; Varella-Garcia, M.; Franklin, W. A.; Camidge, D. R.; more...
    Cancer (2015)

    Fulltext@MSK | Save
  • The impact of genetic heterogeneity on biomarker development in kidney cancer assessed by multiregional sampling
    Journal Article

    Sankin, A.; Hakimi, A. A.; Mikkilineni, N.; Ostrovnaya, I.; Silk, M. T.; Liang, Y.; Mano, R.; Chevinsky, M.; Motzer, R. J.; Solomon, S. B.; more...
    Cancer Medicine (2014)

    Fulltext@MSK | Save
  • Tumor purity and immune cell infiltration as a prognostic risk predictor for clear cell renal cell carcinoma
    Meeting Abstract

    Winer, A. G.; Senbabaoglu, Y.; Kaffenberger, S. D.; Weinhold, N.; Bemis, D.; Coleman, J. A.; Russo, P.; Hsieh, J. J.; Sander, C.; Hakimi, A. A.
    BJU International (2014)

    Fulltext@MSK | Save
  • A critical analysis and validation of the renal cell carcinoma biomarker literature using the cancer genome atlas (TCGA)
    Meeting Abstract

    Kaffenberger, S. D.; Winer, A. G.; Reuter, V.; Coleman, J.; Russo, P.; Hsieh, J. J.; Hakimi, A. A.
    BJU International (2014)

    Fulltext@MSK | Save
  • Whole-exome sequencing predicting two extreme phenotypes of response to VEGF-targeted therapies in metastatic clear cell renal cell carcinoma (mRCC)
    Meeting Abstract

    Fay, A. P.; Van Allen, E. M.; Murray, B.; Albiges, L.; Signoretti, S.; Ho, T. H.; Hakimi, A. A.; Mickey, S.; McDermott, D. F.; Atkins, M. B.; more...
    BJU International (2014)

    Fulltext@MSK | Save
  • Reflex fluorescence in situ hybridization assay for suspicious urinary cytology in patients with bladder cancer with negative surveillance cystoscopy
    Journal Article

    Kim, P. H.; Sukhu, R.; Cordon, B. H.; Sfakianos, J. P.; Sjoberg, D. D.; Hakimi, A. A.; Dalbagni, G.; Lin, O.; Herr, H. W.
    BJU International (2014)

    Fulltext@MSK | Save
  • BRAF mutation predicts for poor outcomes after metastasectomy in patients with metastatic colorectal cancer
    Journal Article

    Yaeger, R.; Cercek, A.; Chou, J. F.; Sylvester, B. E.; Kemeny, N. E.; Hechtman, J. F.; Ladanyi, M.; Rosen, N.; Weiser, M. R.; Capanu, M.; more...
    Cancer (2014)

    Fulltext@MSK | Save
  • External beam radiotherapy with or without concurrent chemotherapy in advanced or recurrent non-anaplastic non-medullary thyroid cancer
    Journal Article

    Romesser, P. B.; Sherman, E. J.; Shaha, A. R.; Lian, M.; Wong, R. J.; Sabra, M.; Rao, S. S.; Fagin, J. A.; Tuttle, R. M.; Lee, N. Y.
    Journal of Surgical Oncology (2014)

    Fulltext@MSK | Save
  • A phase 2 trial of R1507, a monoclonal antibody to the insulin-like growth factor-1 receptor (IGF-1R), in patients with recurrent or refractory rhabdomyosarcoma, osteosarcoma, synovial sarcoma, and other soft tissue sarcomas: Results of a Sarcoma Alliance for Research Through Collaboration study
    Journal Article

    Pappo, A. S.; Vassal, G.; Crowley, J. J.; Bolejack, V.; Hogendoorn, P. C. W.; Chugh, R.; Ladanyi, M.; Grippo, J. F.; Dall, G.; Staddon, A. P.; more...
    Cancer (2014)

    Fulltext@MSK | Save